Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/1/2025

Acute Management of Chest Pain

Initial Assessment and Management

  • The American Heart Association recommends administering aspirin 162-325 mg immediately to patients with suspected cardiac chest pain, preferably non-enteric coated for faster absorption, as it significantly decreases mortality in myocardial infarction 1, 2
  • Early administration of aspirin (within the first few hours of symptom onset) provides greater mortality reduction compared to delayed administration, with high-quality evidence supporting its use 1, 3
  • Aspirin works by inhibiting platelet aggregation, reducing coronary thrombosis formation, and should be chewed and swallowed, with one adult 325-mg tablet or 2-4 low-dose "baby" aspirins (81 mg each) 1, 4
  • The American College of Cardiology recommends calling emergency medical services immediately rather than self-transporting for patients with suspected cardiac chest pain 1
  • Evaluation of the likelihood of cardiac origin (shortness of breath, nausea, sweating, arm/back pain) and obtaining an ECG within 5 minutes if possible are crucial steps in initial assessment 1, 6

Aspirin Administration

  • Aspirin should be administered to patients with suspected cardiac chest pain, with a dose of 162-325 mg, and continued indefinitely (75-162 mg daily) for confirmed acute coronary syndrome (ACS) 1, 2
  • The American Heart Association recommends withholding aspirin in cases of known aspirin allergy, recent bleeding history, or severe active bleeding 1

Warfarin Use

  • Warfarin has no role in the immediate management of acute chest pain or suspected myocardial infarction (MI), but may be considered in specific post-MI scenarios, such as left ventricular thrombus, atrial fibrillation, mechanical heart valve prosthesis, or history of cerebral, venous, or pulmonary emboli 2, 5
  • When warfarin is indicated and combined with aspirin post-MI, the target INR should be 2.0-2.5, and combination therapy increases bleeding risk compared to either agent alone 2

Post-Acute Management

  • The American College of Cardiology recommends continuing aspirin indefinitely (75-162 mg daily) for confirmed ACS, and considering warfarin only for specific indications (atrial fibrillation, LV thrombus, etc.) 2
  • If warfarin is required with aspirin, a lower INR target (2.0-2.5) should be used, and patients should be monitored closely for bleeding 2

Contraindications and Precautions

  • Withholding aspirin in suspected cardiac chest pain delays mortality benefit, and adding warfarin to aspirin without clear indication increases bleeding without benefit 1, 3
  • Using a combination of aspirin and ketorolac significantly increases bleeding risk, and discontinuing aspirin abruptly in patients with coronary stents risks stent thrombosis 7, 2
  • Failing to adjust warfarin dose when combined with aspirin (using a lower INR target) is a precaution to be taken 2